• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Xray Sci Technol . Dynamic CT assessment of disease change and prognosis of patients with moderate COVID-19 pneumonia

tetano

Editor, Senior Moderator
J Xray Sci Technol


. 2020 Jul 29.
doi: 10.3233/XST-200711. Online ahead of print.
Dynamic CT assessment of disease change and prognosis of patients with moderate COVID-19 pneumonia


Hua Zhang[SUP] 1 [/SUP], Xiaohong Liu[SUP] 2 [/SUP], Peng Yu[SUP] 3 [/SUP], Mingyuan Cheng[SUP] 1 [/SUP], Weiting Wang[SUP] 4 [/SUP], Yipeng Sun[SUP] 5 [/SUP], Bingliang Zeng[SUP] 6 [/SUP], Bing Fan[SUP] 6 [/SUP]



Affiliations

Abstract

Objectives: To assess prognosis or dynamic change from initial diagnosis until recovery of the patients with moderate coronavirus disease (COVID-19) pneumonia using chest CT images.
Materials and methods: In this retrospective study, 33 patients (18 men, 15 women; median age, 49.0 years) with confirmed with moderate COVID-19 pneumonia in a multicenter hospital were included. The patients underwent at least four chest non-contrast-enhanced computed tomography (CT) scans at approximately 5-day intervals. We analyzed the clinical and CT characteristics of the patients. Moreover, the total CT score and the sum of lung involvement were determined for every CT scan.
Results: The most widespread presenting symptoms were fever (32/33, 97.0%) and cough (17/33, 51.5%), which were often accompanied by decreased lymphocyte count (15/33, 45.5%) and increased C-reactive protein levels (18/33, 54.6%). Bilateral, multifocal ground glass opacities (32/33, 97.0%), consolidation (25/33, 75.8%), vascular thickening (23/33, 69.7%), and bronchial wall thickening (21/33, 63.6%) with peripheral distribution were the most frequent CT findings during moderate COVID-19 pneumonia. In patients recovering from moderate COVID-19 pneumonia, four stages (stages 1-4) of evolution were identified on chest CT with average CT scores of 3.4?2.3, 6.0?4.4, 5.6?3.8, and 4.9?3.2, respectively, from the onset of symptoms. For most patients, the peak of average total CT score increased for approximately 8 days after the onset of symptoms, after which it decreased gradually. The mean CT score of all patients was 4.7 at the time of discharge.
Conclusion: The moderate COVID-19 pneumonia CT score increased rapidly in a short period of time initially, followed by a slow decline over a relatively long time. The peak of the course occurred in stage 2. Complete recovery of patients with moderate COVID-19 pneumonia with high mean CT score at the time of discharge requires longer time.

Keywords: COVID-19; COVID-19 prognosis; Coronavirus disease; Dynamic CT assessment; Moderate COVID-19 Pneumonia.
 
Back
Top Bottom